Vyvanse, a new ADHD medication has just got approval from the Drug Enforcement Agency (DEA) who classified it as a schedule II controlled substance, the same class as Ritalin, Concerta and many street drugs. This is the final step before Shire PLC can launch the drug commercially. Shire also Adderall, and Adderall XR.
The new drug has been formulated to provide both the long-lasting effects of Adderall XR and to minimise the potential for abuse. ADHD medication are strong stimulants and can be open to abuse both by those it prescribed to and by those who acquire it illegally.